Morgan Stanley
NH

Morgan Stanley’s NantHealth, Inc NH Stock Holding History

Morgan Stanley’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-68
Closed -$248 – 8015
2022
Q4 		$248 Sell
68
-509
-88% -$2.16K ﹤0.01% 7625
2022
Q3 		$2K Sell
577
-2,318
-80% -$16.5K ﹤0.01% 7517
2022
Q2 		$18K Buy
2,895
+2,084
+257% +$19.4K ﹤0.01% 7038
2022
Q1 		$9K Buy
811
+473
+140% +$6.03K ﹤0.01% 7449
2021
Q4 		$5K Sell
338
-4,791
-93% -$101K ﹤0.01% 7671
2021
Q3 		$123K Sell
5,129
-1,764
-26% -$53K ﹤0.01% 6259
2021
Q2 		$240K Buy
6,893
+6,280
+1,024% +$250K ﹤0.01% 5923
2021
Q1 		$29K Sell
613
-9,427
-94% -$546K ﹤0.01% 6589
2020
Q4 		$487K Buy
10,040
+2,457
+32% +$92.4K ﹤0.01% 5095
2020
Q3 		$266K Buy
7,583
+6,665
+726% +$376K ﹤0.01% 4961
2020
Q2 		$63K Buy
918
+554
+152% +$22.1K ﹤0.01% 5605
2020
Q1 		$9K Buy
364
+298
+452% +$7.13K ﹤0.01% 6055
2019
Q4 		$1K Sell
66
-76
-54% -$1.01K ﹤0.01% 6611
2019
Q3 		$1K Sell
142
-227
-62% -$2.02K ﹤0.01% 6594
2019
Q2 		$3K Sell
369
-163
-31% -$1.66K ﹤0.01% 6428
2019
Q1 		$8K Sell
532
-1,943
-79% -$22.5K ﹤0.01% 6248
2018
Q4 		$20K Sell
2,475
-3,471
-58% -$60.8K ﹤0.01% 6023
2018
Q3 		$140K Sell
5,946
-28,240
-83% -$1.07M ﹤0.01% 5588
2018
Q2 		$1.7M Buy
34,186
+8,111
+31% +$401K ﹤0.01% 4230
2018
Q1 		$1.19M Buy
26,075
+12,632
+94% +$634K ﹤0.01% 4419
2017
Q4 		$615K Sell
13,443
-1,407
-9% -$74.6K ﹤0.01% 4855
2017
Q3 		$918K Buy
14,850
+2,431
+20% +$142K ﹤0.01% 4490
2017
Q2 		$788K Buy
12,419
+11,613
+1,441% +$644K ﹤0.01% 4537
2017
Q1 		$60K Sell
806
-988
-55% -$110K ﹤0.01% 5781
2016
Q4 		$268K Buy
1,794
+1,509
+529% +$267K ﹤0.01% 5230
2016
Q3 		$56K Sell
285
-404
-59% -$74.3K ﹤0.01% 5539
2016
Q2 		$129K Buy
+689
New +$150K ﹤0.01% 5129

Other funds holding NH

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley's NH Position: Q1 2023 in Review

Morgan Stanley sold out of NantHealth, Inc (NH) in Q1 2023, closing a stake of 68 shares — an estimated $248 sold.

Morgan Stanley first reported a position in NH in Q2 2016 and held it in 27 quarters. The position peaked at $1.7M in Q2 2018. 18 funds tracked by Wall St. Rank hold NH as of Q1 2023.

  • Morgan Stanley reported no remaining NantHealth, Inc position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 68 NantHealth, Inc shares in Q1 2023, an estimated $248.
  • Morgan Stanley first reported a position in NantHealth, Inc in Q2 2016 and held it in 27 quarters.
  • Morgan Stanley's NantHealth, Inc position peaked at $1.7M in Q2 2018.
  • 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.